Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Medela Potentia Tbk. (MDLA) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Medela Potentia Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Medela Potentia Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Medela Potentia Tbk. trades at Rp208 (market cap 2.91T, 5.49M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Medela Potentia Tbk. is far larger — about 17.5× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Medela Potentia Tbk. is more actively traded (5.49M versus 324K). Which is the better fit depends on your goals.

MDLAOBAT
Market Cap
2.91T166.01B
Volume
5.49M324K
Lot
54.88K3.24K
Turnover
1.14B77.68M
Average Price
208.24239.75
Value
1.14B77.68M
Indicative Equilibrium Price
208240
Indicative Equilibrium Volume
501

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MDLA
View details
OBAT
View details

About Medela Potentia Tbk.

PT Medela Potentia Tbk. (Company) was established based on Deed of Establishment No. 04 dated August 5, 2011, of Public Notary Evy Ferdiana, S.H, Notary of Bekasi Regency, domiciled in Lemah Abang. The Company started its operation activities in 2013.

Read more on MDLA

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT